Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.62 EUR | +0.37% | +6.35% | -20.88% |
Apr. 04 | DERMAPHARM : Berenberg keeps its Buy rating | ZD |
Mar. 28 | Dermapharm Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 1.17B 1.25B | Sales 2025 * | 1.22B 1.31B | Capitalization | 1.8B 1.94B |
---|---|---|---|---|---|
Net income 2024 * | 112M 121M | Net income 2025 * | 130M 140M | EV / Sales 2024 * | 2.24 x |
Net Debt 2024 * | 812M 874M | Net Debt 2025 * | 699M 752M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13.9
x | Employees | 3,497 |
Yield 2024 * |
3.14% | Yield 2025 * |
3.59% | Free-Float | 32.26% |
1 day | +0.75% | ||
1 week | +7.03% | ||
Current month | +6.69% | ||
1 month | +4.69% | ||
3 months | -15.53% | ||
6 months | -11.38% | ||
Current year | -20.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 17-07-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Britta Hamberger
IRC | Investor Relations Contact | - | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 75 | 17-12-31 | |
Wilhelm Beier
CHM | Chairman | 68 | 17-07-31 |
Erwin Kern
BRD | Director/Board Member | 63 | 17-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.01% | 125 M€ | -.--% | ||
0.73% | 17 M€ | -.--% | - | |
0.16% | 79 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 33.5 | 0.00% | 8 843 |
24-05-03 | 33.5 | +4.36% | 42,431 |
24-05-02 | 32.1 | +2.23% | 27,676 |
24-04-30 | 31.4 | -0.32% | 21,554 |
24-04-29 | 31.5 | +0.64% | 19,179 |
Delayed Quote Xetra, May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.88% | 1.94B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- DMP Stock